BACKGROUND: Heroin dependence is a chronic relapsing disease often requiring multiple treatment experiences. Despite this knowledge, few methadone programs follow-up with discharged patients who frequently continue to engage in risky behaviors. The aim of this project was to evaluate the effectiveness of outreach case management for post-discharged methadone patients. METHODS:At 90 days post-discharge 128 active out of treatment heroin users were randomly assigned to receive either a passive referral (PR) for drug treatment (n=52) or were provided with 6 weeks of outreach case management (OCM), an intervention designed to help motivate and coach patients to re-enter treatment (n=76). RESULTS: At 6 months post-baseline 29% of the OCM participants had successfully re-enrolled in drug treatment compared to 8% of the PR participants (chi(2)=7.6, d.f.=1, p=0.006). A logistic regression analysis showed that OCM participants were nearly six times more likely than PR participants to re-engage in MMT (OR=5.8, CI=1.6-20.8, p=0.008). Moreover, OCM subjects had fewer opiate and cocaine positive urines at the 6-month follow-up compared to PR subjects. CONCLUSIONS: The findings highlight the importance of engaging former patients in treatment and actively assisting in treatment re-entry. OCM is a simple approach to reduce the number of out-of-treatment drug users, although availability of treatment funding limits enrollment opportunities.
RCT Entities:
BACKGROUND:Heroin dependence is a chronic relapsing disease often requiring multiple treatment experiences. Despite this knowledge, few methadone programs follow-up with discharged patients who frequently continue to engage in risky behaviors. The aim of this project was to evaluate the effectiveness of outreach case management for post-discharged methadonepatients. METHODS: At 90 days post-discharge 128 active out of treatment heroin users were randomly assigned to receive either a passive referral (PR) for drug treatment (n=52) or were provided with 6 weeks of outreach case management (OCM), an intervention designed to help motivate and coach patients to re-enter treatment (n=76). RESULTS: At 6 months post-baseline 29% of the OCM participants had successfully re-enrolled in drug treatment compared to 8% of the PR participants (chi(2)=7.6, d.f.=1, p=0.006). A logistic regression analysis showed that OCM participants were nearly six times more likely than PR participants to re-engage in MMT (OR=5.8, CI=1.6-20.8, p=0.008). Moreover, OCM subjects had fewer opiate and cocaine positive urines at the 6-month follow-up compared to PR subjects. CONCLUSIONS: The findings highlight the importance of engaging former patients in treatment and actively assisting in treatment re-entry. OCM is a simple approach to reduce the number of out-of-treatment drug users, although availability of treatment funding limits enrollment opportunities.
Authors: Cheryl Teruya; Robert P Schwartz; Shannon Gwin Mitchell; Albert L Hasson; Christie Thomas; Samantha H Buoncristiani; Yih-Ing Hser; Katharina Wiest; Allan J Cohen; Naomi Glick; Petra Jacobs; Paul McLaughlin; Walter Ling Journal: J Psychoactive Drugs Date: 2014 Nov-Dec
Authors: James R McKay; Deborah H A Van Horn; David W Oslin; Kevin G Lynch; Megan Ivey; Kathleen Ward; Michelle L Drapkin; Julie R Becher; Donna M Coviello Journal: J Consult Clin Psychol Date: 2010-12
Authors: Richard C Rapp; Amy L Otto; D Timothy Lane; Cristina Redko; Sue McGatha; Robert G Carlson Journal: Drug Alcohol Depend Date: 2008-02-01 Impact factor: 4.492
Authors: Donna M Coviello; James W Cornish; Kevin G Lynch; Tamara Y Boney; Cynthia A Clark; Joshua D Lee; Peter D Friedmann; Edward V Nunes; Timothy W Kinlock; Michael S Gordon; Robert P Schwartz; Elie S Nuwayser; Charles P O'Brien Journal: Subst Abus Date: 2012 Impact factor: 3.716
Authors: William E Cunningham; Robert E Weiss; Terry Nakazono; Mark A Malek; Steve J Shoptaw; Susan L Ettner; Nina T Harawa Journal: JAMA Intern Med Date: 2018-04-01 Impact factor: 21.873
Authors: Shannon Gwin Mitchell; Rika Morioka; Heather Schacht Reisinger; James A Peterson; Sharon M Kelly; Michael H Agar; Barry S Brown; Kevin E O'Grady; Robert P Schwartz Journal: J Psychoactive Drugs Date: 2011 Apr-Jun
Authors: Michael Prendergast; Lisa Greenwell; Jerome Cartier; Joann Sacks; Linda Frisman; Eleni Rodis; Jennifer R Havens Journal: J Exp Criminol Date: 2009-07-04